Full Press Release Details
REGENERON REPORTS FOURTH QUARTER AND FULL YEAR 2006 FINANCIAL AND OPERATING RESULTS.
REGN
REGENERON REPORTS FOURTH QUARTER AND FULL YEAR 2006 FINANCIAL AND OPERATING RESULTS
Key Takeaway: REGENERON REPORTS FOURTH QUARTER AND FULL YEAR 2006 FINANCIAL AND OPERATING RESULTS
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+35%
120-day peak, hindsight
Typical move
2.6%
average across 15 past catalysts
Lead asset
VEGF Trap-Eye
Phase 1 · Diabetic Macular Edema